Sentences with phrase «into clinical cancer research»

Georgia CORE aims to increase the skills and competencies of the cancer research workforce; raise awareness about the opportunities and benefits of clinical trials; incorporate the perspectives of patients and survivors into clinical cancer research; advocate for clinical trials financing, regulatory improvement and resource development; promote access to and enrollment in clinical trials; and stimulate dialogue and collaboration among multi-disciplinary cancer researchers.

Not exact matches

Wong and his lab want to see if edelfosine could be incorporated into future clinical research focused on other tumor sites such as lung, ovarian and pancreatic cancers.

Research teams focused on both cutaneous and uveal melanoma are fast - tracking discoveries into the clinical setting, and bringing novel therapeutic options to patients in the Philadelphia region,» said Karen Knudsen, Director of the Sidney Kimmel Cancer Center.

The findings, published online in Clinical Cancer Research, offer insight into helping patients assess treatment risk.

During the webinar, our expert panel of researchers will discuss: • Strategies and technologies for successful cancer biomarker discovery through robust detection and analysis of miRNAs in biofluids • Research into analytic and biological variables that impact miRNA measurements in serum and plasma from the clinical pathologist's point of view • The novel application of miRNAs in serum as biomarkers of aging and chronic disease • The answers to questions submitted by the live, online viewers.

Professor Tim Maughan, Clinical Director of the Cancer Research UK / Medical Research Council Oxford Institute for Radiation Oncology, said «This novel and exciting finding provides a new scientific basis for precision targeting of some cancers which are currently very difficult to treat, and we are now taking these findings into clinical trialsClinical Director of the Cancer Research UK / Medical Research Council Oxford Institute for Radiation Oncology, said «This novel and exciting finding provides a new scientific basis for precision targeting of some cancers which are currently very difficult to treat, and we are now taking these findings into clinical trialsclinical trials.»

Bringing together bench and bedside is the purpose of a new institute that aims to become a world - class «translational» cancer research centre, where the knowledge gained from basic research is translated into clinical applications.

Over the years, Dr. Nimer has conducted extensive clinical and basic science research into the treatment and genetic basis of adult leukemia and bone marrow failure states, defining the regulatory mechanisms that control the production of blood cells and exploring ways to improve the treatment of blood based cancers.

In order to obtain the comprehensive designation, which is the highest ranking the National Cancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of basic laboratory research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and coCancer Institute (NCI) gives, a center must meet strict criteria that include a strong core of basic laboratory research in several fields, the ability to translate those research findings into therapies that can one day be used to treat patients, a program of high - priority clinical trials, and a commitment to community service and outreach activities related to cancer prevention and cocancer prevention and control.

Dr. Chodon's current research focus is to determine factors that enhance the development of re-engineered peripheral blood derived stem cells into efficient anti-tumor immune cells, with ability to recognize and kill cancer cells and persist for durable clinical responses.

Included among the numerous recipients of Mr. Sanford's gifts, that total more than one billion dollars, are: the Edith Sanford Foundation for Breast Cancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MedCancer that was created in 2012 by a gift of $ 100 million in honor of Mr. Sanford's mother who died of breast cancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Medcancer when he was four years old; the Sioux Valley Hospitals and Health System, which renamed itself Sanford Health in 2007, in recognition of a $ 400 million gift; a $ 125 million gift in 2014 to establish Sanford Imagenetics, a program that will integrate genomic medicine into primary care for adults; the University of California San Diego which received a $ 100 million gift for the creation of the Sanford Stem Cell Clinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MClinical Center in 2013 to accelerate the translation of stem cell research discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch discoveries by advancing clinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mclinical trials and patient therapies; the Burnham Institute for Medical Research that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch that received a $ 50 million gift in 2010, and recognized its appreciation for both this and a 2008 gift of $ 20 million to the Sanford Center for Childhood Disease research at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Mresearch at Burnham by then changing its name to Sanford Burnham Medical Research Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Institute; a $ 70 million gift to establish a particle physics laboratory named the Sanford Underground Research Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative MResearch Facility; and the San Diego Consortium for Regenerative Medicine which received a gift of $ 30 million in 2008 and expressed its gratitude by renaming itself the Sanford Consortium for Regenerative Medicine.

Together with the research and clinical resources of the nation's leading cancer hospital, we have the ability to take a program from a research hypothesis all the way to a clinical candidate supported by robust preclinical data, and into early phase clinical studies in well - defined patient populations.

There are now multiple immunotherapies targeting clearance of alpha - synuclein from the brain in early - stage clinical trials, and multiple trials underway or in the works on the next generation of cell replacement therapies for dopaminergic neurons, including the TRANSEURO trial; the Summit4StemCell initiative, put together by Jeanne Loring — a researcher at The Scripps Research Institute who is exceptionally engaged with turning her research into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering Cancer Center headed by cell biologist LorenzResearch Institute who is exceptionally engaged with turning her research into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering Cancer Center headed by cell biologist Lorenzresearch into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering Cancer Center headed by cell biologist Lorenz Studer.

NCI supports diverse cancer genomics research and related efforts to translate these findings into clinical advances for patients.

The Wales Cancer Trials Network (WCTN)- jointly funded by Cancer Research UK and the Welsh Assembly Government - was set up in 1998 to overcome these problems and help increase recruitment into high quality, publicly funded cancer clinical tCancer Trials Network (WCTN)- jointly funded by Cancer Research UK and the Welsh Assembly Government - was set up in 1998 to overcome these problems and help increase recruitment into high quality, publicly funded cancer clinical tCancer Research UK and the Welsh Assembly Government - was set up in 1998 to overcome these problems and help increase recruitment into high quality, publicly funded cancer clinical tcancer clinical trials.

We identify and advance therapeutics into clinical trials for children with brain cancer, with increasing focus on types of brain tumors that are uncommon and have the greatest need for translational research.

Cancer Research UK and Cancer Research Technology - the charity's development and commercialisation arm - have reached an agreement with AstraZeneca to take compound AZD - 3965 — a first - of - its - kind experimental drug to potentially treat a range of cancers - into clinical trial.

Physician - scientists at the Cancer Institute engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life.

The results of oncogenomic research should provide new insights into cancer diagnosis, predicting clinical outcomes, and new molecular targets for anti-cancer therapy.

Despite ongoing efforts toward finding novel entities for the treatment of the most challenging cancers, translation into patient benefit has been slow due to the fact that translational cancer research from early drug discovery to late stage drug development and assessment in clinical trials is a long process.

UQDI has strong clinical interactions, world - class facilities, and a greater collaborative research environment, allowing researchers to focus their efforts on turning their scientific discoveries into better treatments for diseases including a variety of cancers, osteoporosis, arthritis, and other autoimmune diseases.

ABOUT THE VAN ANDEL RESEARCH INSTITUTE — STAND UP TO CANCER EPIGENETICS DREAM TEAM The Van Andel Research Institute — Stand Up To Cancer (VARI — SU2C) Epigenetics Dream Team fosters collaboration between several of the world's most respected research and clinical organizations in an effort to translate scientific discoveries into new standards of patieRESEARCH INSTITUTE — STAND UP TO CANCER EPIGENETICS DREAM TEAM The Van Andel Research Institute — Stand Up To Cancer (VARI — SU2C) Epigenetics Dream Team fosters collaboration between several of the world's most respected research and clinical organizations in an effort to translate scientific discoveries into new standards of patieRESEARCH INSTITUTE — STAND UP TO CANCER EPIGENETICS DREAM TEAM The Van Andel Research Institute — Stand Up To Cancer (VARI — SU2C) Epigenetics Dream Team fosters collaboration between several of the world's most respected research and clinical organizations in an effort to translate scientific discoveries into new standards of patieResearch Institute — Stand Up To Cancer (VARI — SU2C) Epigenetics Dream Team fosters collaboration between several of the world's most respected research and clinical organizations in an effort to translate scientific discoveries into new standards of patieResearch Institute — Stand Up To Cancer (VARI — SU2C) Epigenetics Dream Team fosters collaboration between several of the world's most respected research and clinical organizations in an effort to translate scientific discoveries into new standards of patieresearch and clinical organizations in an effort to translate scientific discoveries into new standards of patieresearch and clinical organizations in an effort to translate scientific discoveries into new standards of patient care.

Programs are clustered into Discipline - Based or Disease - Oriented and bring together investigators from all research disciplines (basic, population focused, and clinical) to tackle the challenges of tumor development and progression, diagnosis and treatment, as well as cancer control and disparities.

To prevent and cure cancer through pioneering interdisciplinary research, to translate new knowledge into better prevention and treatment, and to provide effective and compassionate clinical care that improves the lives of patients with cancer and their families.

The next step in this ongoing research project involved translating the findings from basic research into applied clinical research with experimental treatment of human cancer patients.

In the book Cancer & Natural Medicine — A Textbook of Basic Science and Clinical Research, author John Boik identifies a dozen substances which have been shown in vitro to be able to revert cancer cells into normal cells (he calls it «differentiation&raCancer & Natural Medicine — A Textbook of Basic Science and Clinical Research, author John Boik identifies a dozen substances which have been shown in vitro to be able to revert cancer cells into normal cells (he calls it «differentiation&racancer cells into normal cells (he calls it «differentiation»).

In addition to the literature review, focus groups and interviews were conducted with hospital staff, family caregivers and animal - assisted therapy handlers, to glean vital information regarding childhood cancer epidemiology and treatment, the well - being of patients and families who are affected by childhood cancer, the applications of AAT for various populations in need, the state of AAT effectiveness research, and the considerations that need to be made when incorporating therapy animals into clinical settings.

Clinicians also conduct clinical research and three current, ongoing studies include investigations into canine osteosarcoma, the most common bone cancer in dogs; soft tissue sarcomas, the most common type of solid tumors in dogs; and feline fibrosarcoma, injection - site tumors in cats.

All this indicates that curcumin has medicinal properties but that more research into clinical use of turmeric is needed to identify whether pets with cancer will benefit from this spice.

Rockville, MD About Blog The National Cancer Informatics Program (NCIP) supports NCI research initiatives through sustaining a multidisciplinary community of biomedical researchers, informaticists, and developers dedicated to improving informatics practices in the study of cancer and the translation of that knowledge into improved clinical intervenCancer Informatics Program (NCIP) supports NCI research initiatives through sustaining a multidisciplinary community of biomedical researchers, informaticists, and developers dedicated to improving informatics practices in the study of cancer and the translation of that knowledge into improved clinical intervencancer and the translation of that knowledge into improved clinical interventions.